Atrial fibrillation and efficacy of semaglutide 2.4 mg in obesity-related HFpEF: A Patient Level Pooled analysis of STEP-HFpEF and STEP-HFpEF DM trials
30 August 2024 (08:15 - 08:26)
Organised by: 
Slides
About the speaker
St. Luke's Mid America Heart Institute, Kansas City (United States of America)
7 More presentations in this session
Professor S. Verma (Toronto, CA)
Professor S. Verma (Toronto, CA)
Access the full session
The Event
ESC Congress 2024
30 August 2024
08:15 CET
You may be interested in
Congress Presentation
Congress Presentation
